Summit X, LLC Geron Corp Transaction History

Summit X, LLC

$383 Million
Q1 2024

A detailed history of Summit X, LLC transactions in Geron Corp stock. As of the latest transaction made, Summit X, LLC holds 381,670 shares of GERN stock, worth $1.79 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

381,670

Previous 361,961 5.45%

Holding current value

$1.79 Million

Previous $763,000 65.01%

% of portfolio

0.33%

Previous 0.22%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$1.75 - $3.44 $34,490 - $67,798	19,709 Added 5.45%	381,670 $1.26 Million
Q4 2023 Feb 08, 2024	BUY	$1.74 - $2.31 $6,095 - $8,091	3,503 Added 0.98%	361,961 $763,000
Q3 2023 Nov 03, 2023	SELL	$2.11 - $3.28 $8,009 - $12,450	-3,796 Reduced 1.05%	358,458 $759,000
Q2 2023 Aug 09, 2023	SELL	$1.97 - $3.69 $24,656 - $46,184	-12,516 Reduced 3.34%	362,254 $1.16 Million
Q1 2023 May 10, 2023	BUY	$2.14 - $3.4 $581,236 - $923,460	271,606 Added 263.28%	374,770 $813,000

Q4 2022 Feb 02, 2023	SELL	$2.03 - $2.42 $274,979 - $327,808	-135,458 Reduced 56.77%	103,164 $249,000
Q3 2022 Nov 01, 2022	BUY	$1.67 - $2.94 $226,213 - $398,243	135,457 Added 131.3%	238,622 $564,000
Q2 2022 Aug 12, 2022	BUY	$1.19 - $1.65 $14,280 - $19,800	12,000 Added 13.16%	103,165 $165,000
Q1 2022 May 05, 2022	BUY	$0.99 - $1.6 $19,669 - $31,788	19,868 Added 27.87%	91,165 $123,000
Q4 2021 Jan 19, 2022	SELL	$1.22 - $1.72 $15,591 - $21,981	-12,780 Reduced 15.2%	71,297 $86,000
Q3 2021 Oct 19, 2021	SELL	$1.2 - $1.5 $7,122 - $8,902	-5,935 Reduced 6.59%	84,077 $114,000
Q1 2021 May 10, 2021	SELL	$1.52 - $2.1 $57,183 - $79,004	-37,621 Reduced 29.48%	90,012 $144,000
Q4 2020 Jan 29, 2021	SELL	$1.55 - $2.05 $34,324 - $45,397	-22,145 Reduced 14.79%	127,633 $181,000
Q3 2020 Nov 12, 2020	BUY	$1.59 - $2.19 $9,190 - $12,658	5,780 Added 4.01%	149,778 $64,000
Q2 2020 Aug 13, 2020	BUY	$1.05 - $2.18 $42,609 - $88,464	40,580 Added 39.24%	143,998 $314,000
Q1 2020 May 13, 2020	BUY	$0.89 - $1.49 $9,589 - $16,054	10,775 Added 11.63%	103,418 $121,000
Q4 2019 Jan 23, 2020	BUY	$1.27 - $1.54 $45 - $55	36 Added 0.04%	92,643 $125,000
Q3 2019 Oct 15, 2019	BUY	$1.15 - $1.59 $17,825 - $24,645	15,500 Added 20.1%	92,607 $125,000
Q2 2019 Aug 13, 2019	BUY	$1.37 - $2.02 $46,306 - $68,276	33,800 Added 78.05%	77,107 $118,000
Q1 2019 May 13, 2019	BUY	$1.01 - $1.83 $13,678 - $24,783	13,543 Added 45.5%	43,307 $74,000
Q4 2018 Feb 13, 2019	SELL	$0.98 - $1.85 $22,486 - $42,448	-22,945 Reduced 43.53%	29,764 $30,000
Q3 2018 Nov 01, 2018	BUY	$1.76 - $6.38 $24,640 - $89,320	14,000 Added 36.17%	52,709 $53,000
Q2 2018 Sep 24, 2018	BUY	$3.29 - $4.82 $127,352 - $186,577	38,709 New	38,709 $132,000

Others Institutions Holding GERN

# of Institutions

260

Shares Held

373M

Call Options Held

1.48M

Put Options Held

1.18M

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.77B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit X, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit X, LLC with notifications on news.

Account